Investments in associates - Summarised balance sheet (Details) $ in Millions |
12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2025
USD ($)
item
|
Dec. 31, 2024
USD ($)
item
|
Dec. 31, 2023
USD ($)
|
Dec. 31, 2025
USD ($)
item
|
Dec. 31, 2024
USD ($)
item
|
Dec. 31, 2022
USD ($)
|
|||
| Summarised balance sheet | ||||||||
| Non-current assets | $ 6,354 | $ 5,933 | $ 6,354 | $ 5,933 | ||||
| Current assets | 4,103 | 4,421 | 4,103 | 4,421 | ||||
| Non-current liabilities | (3,573) | (3,558) | (3,573) | (3,558) | ||||
| Current liabilities | (1,595) | (1,531) | (1,595) | (1,531) | ||||
| Net equity attributable to owners | 5,289 | 5,265 | $ 5,217 | 5,289 | 5,265 | $ 5,259 | ||
| Group's carrying amount of investment | 121 | 7 | 121 | 7 | ||||
| Associates | ||||||||
| Summarised balance sheet | ||||||||
| Group's carrying amount of investment | 121 | 7 | $ 16 | 121 | 7 | |||
| Bioventus, Inc. | ||||||||
| Summarised balance sheet | ||||||||
| Non-current assets | 421 | 471 | 421 | 471 | ||||
| Current assets | 281 | 299 | 281 | 299 | ||||
| Non-current liabilities | (333) | (371) | (333) | (371) | ||||
| Current liabilities | (162) | (211) | (162) | (211) | ||||
| Net assets | 207 | 188 | 207 | 188 | ||||
| Net equity attributable to owners | 207 | 188 | 207 | 188 | ||||
| Group's share of net assets | 55 | 51 | 55 | 51 | ||||
| Group adjustments | [1] | 64 | (45) | 64 | (45) | |||
| Group's carrying amount of investment | $ 119 | $ 6 | 119 | 6 | ||||
| Percentage of associate held | 26.60% | 27.13% | 27.96% | |||||
| Fair value less cost of disposal | $ 133 | $ 186 | 133 | 186 | ||||
| Cash distributions received | 0 | 0 | ||||||
| Other associates | ||||||||
| Summarised balance sheet | ||||||||
| Group's carrying amount of investment | $ 2 | $ 1 | $ 2 | $ 1 | ||||
| Number of associates | item | 2 | 2 | 2 | 2 | ||||
| ||||||||
| X | ||||||||||
- Definition The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash inflow representing dividends received from associates, classified as investing activities. [Refer: Total for all associates [member]; Dividends received] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of residual interest in the assets of the entity after deducting all its liabilities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of investments in associates accounted for using the equity method. [Refer: Total for all associates [member]; Investments accounted for using equity method] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of assets less the amount of liabilities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of assets that do not meet the definition of current assets. [Refer: Current assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The proportion of ownership interest in an associate attributable to the entity. [Refer: Total for all associates [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of Fair Value Less Cost of Disposal No definition available.
|
| X | ||||||||||
- Definition Adjustments to align the reported amount of net assets of associates accounted for using equity method with the entity's policy for reporting. No definition available.
|
| X | ||||||||||
- Definition The number of additional associates in which the entity reports an equity method investment. No definition available.
|
| X | ||||||||||
- Definition The entity's share of assets from continuing operations of associates and joint ventures accounted for using the equity method. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|